Tarlatamab Rechallenge After Grade 3 Cytokine Release Syndrome Leading to Tumor Regression in Two Weeks and Reopening of a Collapsed Lung: A Case Report

Clin Lung Cancer. 2024 Dec 16:S1525-7304(24)00268-7. doi: 10.1016/j.cllc.2024.12.005. Online ahead of print.

Authors

Timothy Schieber¹, Prakash Neupane², Haoran Li², Chao Huang², Jun Zhang²

Affiliations

¹ The University of Kansas Cancer Center, Westwood, KS. Electronic address: [email protected].
² The University of Kansas Cancer Center, Westwood, KS.

PMID: 39757042
DOI: 10.1016/j.cllc.2024.12.005

No abstract available

Keywords: CNS; CRS; IMRT; Onset; Radiation; Rapid; Rechallenge; Tarlatamab.

Publication types

Case Reports